Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Dosing for VTE Prophylaxis in Bariatric Surgery
NCT01970202Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2013
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01970202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970202.